Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Antidepressant
TGBA01AD
Другие языки:

    TGBA01AD

    Подписчиков: 0, рейтинг: 0
    TGBA01AD
    Clinical data
    Other names FKB01MD
    Routes of
    administration    		 By mouth
    Pharmacokinetic data
    Bioavailability 17%
    Elimination half-life 4 hours
    Chemical and physical data
    3D model (JSmol)
    • OCC1OC(C(O)C1O)C2(O)NC=CC(=O)N2
    • InChI=1S/C9H14N2O6/c12-3-4-6(14)7(15)8(17-4)9(16)10-2-1-5(13)11-9/h1-2,4,6-8,10,12,14-16H,3H2,(H,11,13)
    • Key:QJTQVQQHNGHIKY-UHFFFAOYSA-N

    TGBA01AD (also known as FKB01MD) is a serotonin reuptake inhibitor, 5-HT1A and 5-HT1D receptor agonist, and 5-HT2 receptor antagonist which is under development by Fabre-Kramer for the treatment of major depressive disorder. It has been in phase II clinical trials since 2009, and as of January 2016, remains in this phase of development.

    See also


    Новое сообщение